Caffeine Labeling and GRAS Review
Current understanding
Federal policy on caffeine disclosure in foods, beverages, and dietary supplements, and on caffeine’s Generally Recognized as Safe (GRAS) status under the FDA. HR2511 (Sarah Katz Caffeine Safety Act) was introduced and would require caffeine content labeling on products containing more than 10 mg of caffeine, mandate ‘high caffeine’ menu disclosures at large restaurant chains, and direct the FDA to reassess caffeine’s GRAS designation. Effects on consumers would center on clearer dosing information; effects on manufacturers and restaurants would depend on labeling reformulation and menu compliance costs, with potential downstream pricing implications.
Evidence log
- 2025-08-12 — GRAS Act: cross-connection with gras-food-ingredient-safety: Both address the FDA GRAS determination pathway; the GRAS Act reform would set the framework under which specific substance reviews (e.g., caffeine) operate. (novelty: 3)
- 2025-03-31 — Sarah Katz Caffeine Safety Act: cross-connection with celiac-safety-labeling: Both are FDA-administered consumer disclosure regimes for ingested substances (caffeine content vs. gluten), reflecting a parallel legislative push on food/supplement labeling transparency. (novelty: 2)